✦ LIBER ✦

PSR2 EVALUATING THE POTENTIAL COST-EFFECTIVENESS OF FUTURE ANTICOAGULANT DRUGS VS. WARFARIN IN THE PREVENTION OF STROKE AND MAJOR BLEEDS IN ATRIAL FIBRILLATION PATIENTS

✍ Scribed by T Arant; P Sullivan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Rivaroxaban in the

✍ Capri, S.; Veneziano, M.; Ricciardi, W.G.; D’Ausilio, A.; Pedone, M.P.; Bianchi, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

The cost–effectiveness of rivaroxaban fo

✍ Marmarali, B.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

An Analysis of the Cost Effectiveness of

✍ Reddy, V.Y.; Akehurst, R.L.; Amorosi, S.L.; Armstrong, S.; Holmes, D.R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-effectiveness of rivaroxaban for th

✍ Asukai, Y.; Maniadakis, N.; Carcedo, D.; Lukac, M.; Evers, T. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV56 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB